CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Deferred Tax Assets, Gross
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) had Deferred Tax Assets, Gross of -$79.64 million as of 2014-12-27, per its 10-K filed 2015-02-17.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsGross · last filed 2015-02-17
- 2014-12-27: Deferred Tax Assets, Gross -$79.64M.
- 2013-12-28: Deferred Tax Assets, Gross -$46.94M; Deferred Tax Assets, Gross as first filed $54.80M.
- 2012-12-29: Deferred Tax Assets, Gross $62.52M.
| Period end | Deferred Tax Assets, Gross | Deferred Tax Assets, Gross as first filed |
|---|---|---|
| 2014-12-27 | -$79.64M 10-K · filed 2015-02-17 | |
| 2013-12-28 | -$46.94M 10-K · filed 2015-02-17 | $54.80M 10-K · filed 2014-02-25 |
| 2012-12-29 | $62.52M 10-K · filed 2014-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |